Podcasts by Category

The Economist Podcasts

The Economist Podcasts

The Economist
Every weekday our global network of correspondents makes sense of the stories beneath the headlines. We bring you surprising trends and tales from around the world, current affairs, business and finance—as well as science and technology.

Hosted on Acast. See acast.com/privacy for more information.

4306 - Lula loop: meeting Brazil’s presidential front-runner
0:00 / 0:00
1x
  • 4306 - Lula loop: meeting Brazil’s presidential front-runner

    Luiz Inácio Lula da Silva, a leftist former president, looks well-placed to win a third term. But which Lula would Brazil get—the fiscal conservative or the populist spendthrift? Germany has an earned reputation as an industrial powerhouse, but its dependence on Russian gas and Chinese demand are hobbling it. And why the propaganda-spewing loudspeakers in Vietnam’s capital are firing up again.

    For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer



    Hosted on Acast. See acast.com/privacy for more information.

    Thu, 29 Sep 2022 - 26min
  • 4305 - Money Talks: The rate shock

    The world’s financial markets are going through their most painful adjustment since the global financial crisis. Global stock markets have sold off sharply and bond markets are on course for their worst year since 1949. The British pound briefly fell to its lowest level ever against the dollar. And the Japanese government has intervened to prop up the value of the yen for the first time since 1998. What’s underlying this shift?


    On this week’s episode, hosts Alice Fulwood, Mike Bird and Soumaya Keynes are joined by our business affairs editor Patrick Foulis to parse the fallout from this month’s synchronous decision by the majority of the world’s central banks to raise interest rates. They’ll look at the idiosyncrasies of two outliers: Britain, where the government’s tax cuts are at odds with the Bank of England’s desire to reign in prices, and Japan, where the central bank recently decided to keep rates negative. Plus, Blue Bay Asset Management’s chief investment officer Mark Dowding explains why he’s decided to bet against sterling. And former Bank of Japan policy committee member Goushi Kataoka outlines why he thinks a weak yen could spell opportunity for Japan’s ailing economy.


    Sign up for our new weekly newsletter dissecting the big themes in markets, business and the economy at www.economist.com/moneytalks 

    For full access to print, digital and audio editions, subscribe to The Economistat www.economist.com/podcastoffer



    Hosted on Acast. See acast.com/privacy for more information.

    Wed, 28 Sep 2022 - 33min
  • 4304 - Off the top of their heads: Iran’s widespread protests

    Women are burning their hijabs on bonfires and hacking off their hair—but the unrest has come to be about far more than the heavy hands of the morality police. The murder of Abe Shinzo, a former Japanese prime minister, exposed troubling government links to a cult-like sect; the fallout could unseat his successor. And using flying robots as 3D printers. For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer


    Hosted on Acast. See acast.com/privacy for more information.

    Wed, 28 Sep 2022 - 25min
  • 4303 - Babbage: How psychedelics could fix the brain

    Psychedelic drugs—such as LSD and psilocybin, the psychoactive compound found in magic mushrooms—may be coming to the medicine cabinet. Research into their use to treat mental-health conditions was long blocked by law and stigma. But in recent years, there has been a revival of interest in the drugs, which are now being trialled to treat conditions such as depression. The Economist’s Ainslie Johnstone visits one of Britain's most high-profile psilocybin research facilities, and investigates how the drug could help scientists better understand autism. And, as investors pile in, Natasha Loder, our health policy editor, separates the hope from the hype. Plus, we ask whether the drugs’ hallucinatory effects are necessary for their health benefits, and meet a researcher who hopes to develop psychedelics without the trip. Alok Jha hosts.


    Listen to our other episodes on psychedelics in health care at economist.com/psychedelics-pod.


    For full access to The Economist’s print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyscience.



    Hosted on Acast. See acast.com/privacy for more information.

    Tue, 27 Sep 2022 - 44min
  • 4302 - In for a penny, in for a pounding: Britain’s economic gyrations

    The markets are so far entirely unconvinced that the new administration’s Reagan-esque economic plans will work to spur growth—just look at sterling's tumble. In Tibet, China’s mass collection of DNA samples has one unabashed motive: social control. And the curious wave of “unretirees” returning to work after the pandemic.

    Additional audio courtesy of the Ronald Reagan Presidential Library.

    For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer



    Hosted on Acast. See acast.com/privacy for more information.

    Tue, 27 Sep 2022 - 23min
Show More Episodes